Loading...
XNAS
GDRX
Market cap1.02bUSD
Jul 09, Last price  
2.94USD
1D
-0.68%
1Q
34.25%
IPO
-93.70%
Name

GoodRx Holdings Inc

Chart & Performance

D1W1MN
XNAS:GDRX chart
P/E
33.48
P/S
1.28
EPS
0.09
Div Yield, %
Shrs. gr., 5y
5.38%
Rev. gr., 5y
7.67%
Revenues
797m
+0.57%
99,377,000157,240,000249,522,000388,224,000550,700,000745,424,000766,554,000750,265,000792,324,000796,853,000
Net income
30m
+85.72%
-7,774,0008,843,00043,793,00066,048,000-293,623,000-25,254,000-32,828,000-8,868,00016,390,00030,439,000
CFO
168m
-8.69%
45,253,00083,286,000131,341,000178,779,000146,780,000138,292,000183,892,000167,904,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
IPO date
Sep 23, 2020
Employees
952
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT